Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1980 Apr;35:181–190. doi: 10.1289/ehp.8035181

Prostaglandins evoke a whole variety of responses in the lung.

P J Kadowitz, E W Spannhake, A L Hyman
PMCID: PMC1568459  PMID: 6997027

Abstract

Rapid intravenous (IV) injections of the prostaglandin precursor arachidonic acid (AA) increase pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) in a variety of species. It has recently been reported that infusions of AA decrease PAP. The purpose of this report is to contrast responses to bolus injections and infusions of AA in the anesthetized dog. In all experiments rapid IV injections of AA increased PAP and PVR; however, infusions of 68 to 680 microgram/min produced variable responses. In 10 of 19 animals, AA infusion decreased PAP and PVR, and this response was enhanced when pulmonary vascular tone was actively increased by vasoconstrictor agents or alveolar hypoxia. In the other nine animals, the predominant response was an increase in PAP and PVR. In all experiments infusions of larger amounts of AA (1.4 to 3.4 mg/min) increased PAP. Both pressor and depressor responses to AA were inhibited to meclofenamate. This study shows that infusion of small amounts of AA dilates or constricts the pulmonary vascular bed. In contrast, infusion of larger amounts of AA always causes vasoconstriction. These data suggest that at low infusion rate, PGI2, which is a vasodilator, is the predominant metabolite formed from AA in some animals. However, at higher concentrations, the production of constrictor products predominates. These experiments also suggest that the products formed and the response observed may be dependent on a number of factors including the amount of tone present in the pulmonary vascular bed.

Full text

PDF
181

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bunting S., Gryglewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976 Dec;12(6):897–913. doi: 10.1016/0090-6980(76)90125-8. [DOI] [PubMed] [Google Scholar]
  2. Cassin S., Tyler T., Leffler C., Wallis R. Pulmonary and systemic vascular responses of perinatal goats to prostaglandins E1 and E2. Am J Physiol. 1979 Jun;236(6):H828–H832. doi: 10.1152/ajpheart.1979.236.6.H828. [DOI] [PubMed] [Google Scholar]
  3. Gruetter C. A., McNamara D. B., Hyman A. L., Kadowitz P. J. Contractile responses of intrapulmonary vessels from three species to arachidonic acid and an epoxymethano analog of PGH2. Can J Physiol Pharmacol. 1978 Apr;56(2):206–215. doi: 10.1139/y78-030. [DOI] [PubMed] [Google Scholar]
  4. Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins. 1976 Nov;12(5):685–713. doi: 10.1016/0090-6980(76)90047-2. [DOI] [PubMed] [Google Scholar]
  5. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. VII. Novel transformations of arachidonic acid in guinea pig lung. Biochem Biophys Res Commun. 1974 Dec 11;61(3):942–949. doi: 10.1016/0006-291x(74)90246-0. [DOI] [PubMed] [Google Scholar]
  6. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hamberg M., Svensson J., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci U S A. 1974 Feb;71(2):345–349. doi: 10.1073/pnas.71.2.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hyman A. L., Chapnick B. M., Kadowitz P. J., Lands W. E., Crawford C. G., Fried J., Barton J. Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5711–5715. doi: 10.1073/pnas.74.12.5711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hyman A. L., Kadowitz P. J., Lands W. E., Crawford C. G., Fried J., Barton J. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3522–3526. doi: 10.1073/pnas.75.7.3522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hyman A. L., Kadowitz P. J. Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat. Circ Res. 1979 Sep;45(3):404–409. doi: 10.1161/01.res.45.3.404. [DOI] [PubMed] [Google Scholar]
  11. Hyman A. L., Mathe A. A., Leslie C. A., Matthews C. C., Bennett J. T., Spannhake E. W., Kadowitz P. J. Modification of pulmonary vascular responses to arachidonic acid by alterations in physiologic state. J Pharmacol Exp Ther. 1978 Nov;207(2):388–401. [PubMed] [Google Scholar]
  12. Kadowitz P. J., Chapnick B. M., Feigen L. P., Hyman A. L., Nelson P. K., Spannhake E. W. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2. J Appl Physiol Respir Environ Exerc Physiol. 1978 Sep;45(3):408–413. doi: 10.1152/jappl.1978.45.3.408. [DOI] [PubMed] [Google Scholar]
  13. Kadowitz P. J., Chapnick B. M., Joiner P. D., Hyman A. L. Influence of inhibitors of prostaglandin synthesis on the canine pulmonary vascular bed. Am J Physiol. 1975 Oct;229(4):941–946. doi: 10.1152/ajplegacy.1975.229.4.941. [DOI] [PubMed] [Google Scholar]
  14. Kadowitz P. J., Gruetter C. A., McNamara D. B., Gorman R. R., Spannhake E. W., Hyman A. L. Comparative effects of endoperoxide PGH2 and an analog on the pulmonary vascular bed. J Appl Physiol Respir Environ Exerc Physiol. 1977 Jun;42(6):953–958. doi: 10.1152/jappl.1977.42.6.953. [DOI] [PubMed] [Google Scholar]
  15. Kadowitz P. J., Hyman A. L. Influence of a prostaglandin endoperoxide analogue on the canine pulmonary vascular bed. Circ Res. 1977 Mar;40(3):282–287. doi: 10.1161/01.res.40.3.282. [DOI] [PubMed] [Google Scholar]
  16. Kadowitz P. J., Joiner P. D., Hyman A. L. Effect of prostaglandin E2 on pulmonary vascular resistance in intact dog, swine and lamb. Eur J Pharmacol. 1975 Mar;31(1):72–80. doi: 10.1016/0014-2999(75)90080-1. [DOI] [PubMed] [Google Scholar]
  17. Kadowitz P. J., Spannhake E. W., Greenberg S., Feigen L. P., Hyman A. Comparative effects of arachidonic acid, bisenoic prostaglandins, and an endoperoxide analog on the canine pulmonary vascular bed. Can J Physiol Pharmacol. 1977 Dec;55(6):1369–1377. doi: 10.1139/y77-182. [DOI] [PubMed] [Google Scholar]
  18. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
  19. Nugteren D. H., Hazelhof E. Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim Biophys Acta. 1973 Dec 20;326(3):448–461. doi: 10.1016/0005-2760(73)90145-8. [DOI] [PubMed] [Google Scholar]
  20. Pace-Asciak C. R. Oxidative biotransformations of arachidonic acid. Prostaglandins. 1977 May;13(5):811–817. doi: 10.1016/0090-6980(77)90211-8. [DOI] [PubMed] [Google Scholar]
  21. Spannhake E. W., Lemen R. J., Wegmann M. J., Hyman A. L., Kadowitz P. J. Analysis of airway effects of a PGH2 analog in the anesthetized dog. J Appl Physiol Respir Environ Exerc Physiol. 1978 Mar;44(3):406–415. doi: 10.1152/jappl.1978.44.3.406. [DOI] [PubMed] [Google Scholar]
  22. Spannhake E. W., Lemen R. J., Wegmann M. J., Hyman A. L., Kadowitz P. J. Effects of arachidonic acid and prostaglandins on lung function in the intact dog. J Appl Physiol Respir Environ Exerc Physiol. 1978 Mar;44(3):397–405. doi: 10.1152/jappl.1978.44.3.397. [DOI] [PubMed] [Google Scholar]
  23. Wicks T. C., Rose J. C., Johnson M., Ramwell P. W., Kot P. A. Vascular responses to arachidonic acid in the perfused canine lung. Circ Res. 1976 Mar;38(3):167–171. doi: 10.1161/01.res.38.3.167. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES